local_hospital

Centrum ambulantni gynekologie a primarni pece s.r.o.

Address
Orli 488/10, Brno-Mesto, 602 00 Brno-střed, Czechia

Female Urogenital Health and Pregnancy-Related Research

At Centrum ambulantni gynekologie a primarni pece s.r.o., clinical research in gynecology focuses on female urogenital diseases and pregnancy-related concerns, with studies centered on oral contraception and prevention of pregnancy. The trials are designed to assess how well contraceptive options work and how they are tolerated in everyday use.

  • Evaluating the contraceptive effectiveness of new and existing birth control approaches
  • Studying the safety and tolerability of hormonal contraception in women
  • Assessing reproductive health outcomes relevant to routine gynecologic care

This research helps improve options for women seeking reliable contraception while supporting broader care in a busy gynecologic outpatient clinic.

Menstrual Symptom Relief and Reproductive Physiology

Another key area at this Brno site is the study of reproductive and urinary physiological phenomena, especially primary dysmenorrhea. The research is aimed at finding better ways to ease menstrual pain and improve comfort for women affected by cramping and related symptoms.

  • Investigating treatments for menstrual pain and cramping
  • Comparing symptom improvement with placebo to understand treatment benefit
  • Supporting better management of common women’s health complaints

These studies focus on practical symptom relief and on identifying therapies that may offer meaningful improvement in menstrual health.

Viral Infection Prevention and HPV Research

The site also contributes to virus disease research through work on human papillomavirus prevention. One trial examines whether vaccination can reduce persistent oral infection linked to several high-risk HPV types, reflecting a preventive approach to infectious disease control.

  • Testing a vaccine strategy to reduce HPV-related oral infection
  • Exploring prevention of long-lasting infection in adult men
  • Supporting broader efforts in virus prevention and public health

This line of research helps clarify how preventive interventions may lower the burden of HPV infection and its related health risks.

Contraceptive Innovation and Bone Health

Research at the clinic also looks at how contraceptive methods affect overall health, including musculoskeletal outcomes such as bone mineral density. These studies compare different contraceptive approaches to better understand their impact beyond pregnancy prevention.

  • Assessing the effectiveness of a vaginal contraceptive system
  • Examining how certain contraceptives influence bone health
  • Comparing hormonal and non-hormonal options for broader women’s health insight

By combining contraceptive evaluation with attention to skeletal health, the studies support more informed choices for adolescents and adult women.

Site Overview

assignment
4
connected trials
corporate_fare
3
sponsors
science
12
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
4
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
3
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 634 other sites in Czechia

description
Trial volume
4
Outperforms 68% of sites
public
Therapeutic diversity
4areas
Outperforms 88% of sites
groups
Sponsor diversity
3sponsors
Outperforms 68% of sites

Therapeutic Area Benchmark — Czechia

Select a therapeutic area to compare against other sites in Czechia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Czechia

Market Share

Country: Czechia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centrum ambulantni gynekologie a primarni pece s.r.o.

lock Showing 1 of 4 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.Chemo Research S.L.Phase IIINot RecruitingJul 2023Aug 2025

IMP list

lock Showing 1 of 12 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
DROSPIRENONE1Unknown2022-08-222022-08-22

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.